Trials / Recruiting
RecruitingNCT07065682
Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- Sponsor
- Universitas Diponegoro · Academic / Other
- Sex
- Male
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This study is a double blinded RCT with pre-post test design on the effect of combination of dutasteride and aloe vera, compared to dutasteride only, on uroflowmetry results, prostate volume, and VEGF serum level among patients with benign prostate hyperplasia. The treatment was given for 12 weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aloevera + dutasteride | Dutasteride 0,5 mg/day + Aloe Vera Extract 380 mg/day |
| DRUG | Dutasteride (0.5mg) | Control |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2024-12-01
- Completion
- 2027-12-01
- First posted
- 2025-07-15
- Last updated
- 2025-07-15
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT07065682. Inclusion in this directory is not an endorsement.